IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishChorea is the most common movement disorder associated to autoimmune diseases and one of the first non thrombotic neurological complications associated with antiphospholipid antibodies (aPL). Several treatment options have been considered, especially in young patients that failed to respond to conventional therapy. In the last years Intravenous immunoglobulin treatment (IVIG) are largely administered with beneficial and rapid effect not only in adult patients affected by autoimmune diseases, but also in children. IVIG treatment could be considered as therapeutic option also in children with antiphospholipid related chorea.
Brogna, C., Mariotti, P., Manna, R., Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea, <<LUPUS>>, 2014; 23 (14): 1449-1451. [doi:10.1177/0961203314551084] [http://hdl.handle.net/10807/122823]
| Autori: | |
| Titolo: | Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1177/0961203314551084 |
| URL: | http://lup.sagepub.com/content/23/14/1449.long |
| Data di pubblicazione: | 2014 |
| Abstract: | Chorea is the most common movement disorder associated to autoimmune diseases and one of the first non thrombotic neurological complications associated with antiphospholipid antibodies (aPL). Several treatment options have been considered, especially in young patients that failed to respond to conventional therapy. In the last years Intravenous immunoglobulin treatment (IVIG) are largely administered with beneficial and rapid effect not only in adult patients affected by autoimmune diseases, but also in children. IVIG treatment could be considered as therapeutic option also in children with antiphospholipid related chorea. |
| Lingua: | Inglese |
| Rivista: | |
| Citazione: | Brogna, C., Mariotti, P., Manna, R., Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea, <<LUPUS>>, 2014; 23 (14): 1449-1451. [doi:10.1177/0961203314551084] [http://hdl.handle.net/10807/122823] |
| Appare nelle tipologie: | Editoriale in rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Note | Licenza | |
|---|---|---|---|---|---|
| editoriale lupus.pdf | N/A | Nessuna Nota | Open Access Visualizza/Apri |
Copyright © 2021